Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Drugs Made In America Acq...

    NASDAQ: DMAA · Real-Time Price · USD
    10.27
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:39 PM
    10.29
    0.19%
    After-hours: Oct 03, 2025, 04:04 PM EDT

    Drugs Made In America Acquisition Ordinary Shares Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024
    Period Ending Dec 31, 2024
    PE Ratio
    		 -178.22
    PEG Ratio
    		 n/a
    PS Ratio
    		 n/a
    PB Ratio
    		 -349.87
    P/FCF Ratio
    		 -289.38
    P/OCF Ratio
    		 -289.38
    OCF/S Ratio
    		 n/a
    Debt / Equity Ratio
    		 -2.71
    Quick Ratio
    		 6.27
    Current Ratio
    		 6.27
    Asset Turnover
    		 n/a
    Interest Coverage
    		 n/a
    Return on Equity
    		 1.96
    Return on Assets
    		 -0.87
    Return on Invested Capital
    		 -0.09
    Dividend Yield
    		 n/a
    Payout Ratio
    		 n/a
    Gross Profit Margin
    		 n/a
    Net Profit Margin
    		 n/a
    Pretax Profit Margin
    		 n/a
    Operating Profit Margin
    		 n/a
    FCF Margin
    		 n/a
    EBITDA Margin
    		 n/a

    Add to Watchlist